In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy
Novo Nordisk blames middlemen in U.S. healthcare system for high prices of weight loss drugs Wegovy and Ozempic
Read Next
- Gen Z Forgets About Tax Refunds: 54% of Gen Z Don’t Know the Tax Deadline (A Turbotax Survey)
- The Rise of Prop Trading in 2025: Prop Firms Change the Game
- eToro launches staking for Polkadot and Cosmos
- Nvidia positioned to weather Trump tariffs, says Altimeter’s Gerstner
- Southwest’s bag fees and other changes could backfire, Fitch warns
- How to Get a Month Ahead With Your Budget
- TA Associates buys out Hg’s position in trading platform provider smartTrade
